Evaluation of the effect of pretreatment of E2 and OCP in Antagonist cycle In IVF cycles.
Phase 2
- Conditions
- Female infertility associated with anovulation.Female infertility, unspecified
- Registration Number
- IRCT2017020520351N9
- Lead Sponsor
- Vice Chancellor for Research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 195
Inclusion Criteria
women with 20-35 years old; prior IVF less than 2; AFC>4; FSH<10; without any pathology in ovary or endometrioma more than 1cm; without any hydrosalpinx.
Exclusion criteria: PCOS; pathology in uterus or ovary ( myoma larger than 5 cm); absence of vaginal bleeding until 6 days after disconnection of OCP or E2; lack of permission of patients.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oocyte number. Timepoint: Six days after treatment. Method of measurement: Vaginal sonography.;Number of induction ovulation. Timepoint: After treatment. Method of measurement: Transvaginal sonography.
- Secondary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: B-HCG Test.;Clinical pregnancy. Timepoint: Three weeks after do positive of pregnancy teset. Method of measurement: Transvaginal sonography.